Cocrystal Pharma, Inc. beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.17 | $-0.23 | -35.3% | Miss |
| Q12026 FY2026 | $-0.15 | $-0.17 | -13.3% | Miss |
| Q42025 FY2025 | $-0.18 | $-0.17 | +5.6% | Beat |
Back to COCP overview · COCP holders · COCP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.